Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 130

1.

AlleleAnalyzer: a tool for personalized and allele-specific sgRNA design.

Keough KC, Lyalina S, Olvera MP, Whalen S, Conklin BR, Pollard KS.

Genome Biol. 2019 Aug 15;20(1):167. doi: 10.1186/s13059-019-1783-3.

2.

Women's Cigarette and Marijuana Use in Pregnancy: Identifying the Role of Past Versus Recent Violence Exposure.

Miller-Graff LE, Howell KH, Grein K, Keough K.

J Interpers Violence. 2018 Jun 1:886260518779068. doi: 10.1177/0886260518779068. [Epub ahead of print]

PMID:
29936890
3.

Child Neurology Residency Program Directors and Program Coordinators 2016 Workforce Survey.

Gilbert DL, LaBare JA, Keough K, Feist TB.

Pediatr Neurol. 2018 Feb;79:21-27. doi: 10.1016/j.pediatrneurol.2017.10.021. Epub 2017 Nov 6.

PMID:
29203344
4.

Clinical reasoning: novel GLUT1-DS mutation: refractory seizures and ataxia.

Sen S, Keough K, Gibson J.

Neurology. 2015 Apr 14;84(15):e111-4. doi: 10.1212/WNL.0000000000001467.

PMID:
25870456
5.

Aseptic meningitis outbreak associated with echovirus 30 among high school football players--Los Angeles County, California, 2014.

Croker C, Civen R, Keough K, Ngo V, Marutani A, Schwartz B; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2015 Jan 2;63(51):1228.

6.

A special focus issue on the materials of PRION 2013 meeting in Banff, Alberta Canada.

Keough K, Cashman N.

Prion. 2014 Jan-Feb;8(1):1. No abstract available.

PMID:
25077317
7.

Immunoreceptor tyrosine-based inhibitory motif (ITIM)-mediated inhibitory signaling is regulated by sequential phosphorylation mediated by distinct nonreceptor tyrosine kinases: a case study involving PECAM-1.

Tourdot BE, Brenner MK, Keough KC, Holyst T, Newman PJ, Newman DK.

Biochemistry. 2013 Apr 16;52(15):2597-608. doi: 10.1021/bi301461t. Epub 2013 Apr 3.

8.

Bacterial lipopolysaccharide promotes destabilization of lung surfactant-like films.

Cañadas O, Keough KM, Casals C.

Biophys J. 2011 Jan 5;100(1):108-16. doi: 10.1016/j.bpj.2010.11.028.

9.

Group identification and college adjustment: the experience of encountering a novel stereotype.

Newman ML, Keough KA, Lee RM.

J Soc Psychol. 2009 Dec;149(6):694-708. doi: 10.1080/00224540903348261.

PMID:
20099567
10.

SP-A permeabilizes lipopolysaccharide membranes by forming protein aggregates that extract lipids from the membrane.

Cañadas O, García-Verdugo I, Keough KM, Casals C.

Biophys J. 2008 Oct;95(7):3287-94. doi: 10.1529/biophysj.108.137323. Epub 2008 Jul 3.

11.

Structure of mini-B, a functional fragment of surfactant protein B, in detergent micelles.

Sarker M, Waring AJ, Walther FJ, Keough KM, Booth V.

Biochemistry. 2007 Oct 2;46(39):11047-56. Epub 2007 Sep 11.

PMID:
17845058
12.

Surfactant protein A forms extensive lattice-like structures on 1,2-dipalmitoylphosphatidylcholine/rough-lipopolysaccharide-mixed monolayers.

García-Verdugo I, Cañadas O, Taneva SG, Keough KM, Casals C.

Biophys J. 2007 Nov 15;93(10):3529-40. Epub 2007 Aug 10.

13.

Differential effects of human SP-A1 and SP-A2 variants on phospholipid monolayers containing surfactant protein B.

Wang G, Taneva S, Keough KM, Floros J.

Biochim Biophys Acta. 2007 Sep;1768(9):2060-9. Epub 2007 Jul 6.

14.

Comparison of DPPC and DPPG environments in pulmonary surfactant models.

Morrow MR, Temple S, Stewart J, Keough KM.

Biophys J. 2007 Jul 1;93(1):164-75. Epub 2007 Apr 13.

15.

Effect of chain unsaturation on bilayer response to pressure.

Skanes ID, Stewart J, Keough KM, Morrow MR.

Phys Rev E Stat Nonlin Soft Matter Phys. 2006 Nov;74(5 Pt 1):051913. Epub 2006 Nov 20.

PMID:
17279945
16.

An X-ray diffraction study of alterations in bovine lung surfactant bilayer structures induced by albumin.

Larsson M, Nylander T, Keough KM, Nag K.

Chem Phys Lipids. 2006 Nov-Dec;144(2):137-45. Epub 2006 Sep 8.

PMID:
17055468
17.

Probing perturbation of bovine lung surfactant extracts by albumin using DSC and 2H-NMR.

Nag K, Keough KM, Morrow MR.

Biophys J. 2006 May 15;90(10):3632-42. Epub 2006 Feb 24.

18.

Interaction of the N-terminal segment of pulmonary surfactant protein SP-C with interfacial phospholipid films.

Plasencia I, Keough KM, Perez-Gil J.

Biochim Biophys Acta. 2005 Jul 30;1713(2):118-28.

19.

NMR structures of the C-terminal segment of surfactant protein B in detergent micelles and hexafluoro-2-propanol.

Booth V, Waring AJ, Walther FJ, Keough KM.

Biochemistry. 2004 Dec 7;43(48):15187-94.

PMID:
15568810
20.

Managing pain: The Challenge in Underserved Populations: Appropriate Use Versus Abuse and Diversion.

Primm BJ, Perez L, Dennis GC, Benjamin L, Clark W, Keough K, Leak WD, Payne R, Smith D, Sullivan LW; National Medical Association.

J Natl Med Assoc. 2004 Sep;96(9):1152-61. Review.

21.

How thin can glass be? New ideas, new approaches.

Keough K.

Biophys J. 2003 Nov;85(5):2785-6. No abstract available.

22.
23.

Interaction of pulmonary surfactant protein SP-A with DPPC/egg-PG bilayers.

Morrow MR, Abu-Libdeh N, Stewart J, Keough KM.

Biophys J. 2003 Oct;85(4):2397-405.

24.

Perturbation of DPPC bilayers by high concentrations of pulmonary surfactant protein SP-B.

Morrow MR, Stewart J, Taneva S, Dico A, Keough KM.

Eur Biophys J. 2004 Jul;33(4):285-90. Epub 2003 Sep 23.

PMID:
14504839
25.

Location of structural transitions in an isotopically labeled lung surfactant SP-B peptide by IRRAS.

Flach CR, Cai P, Dieudonné D, Brauner JW, Keough KM, Stewart J, Mendelsohn R.

Biophys J. 2003 Jul;85(1):340-9.

26.

The use of pulmonary interstitial emphysema as an indicator of live birth.

Lavezzi WA, Keough KM, Der'Ohannesian P, Person TL, Wolf BC.

Am J Forensic Med Pathol. 2003 Mar;24(1):87-91.

PMID:
12605006
27.

The Third Amyot Lecture. How science informs the decisions of government.

Keough K.

Can J Public Health. 2002 Mar-Apr;93(2):104-8. No abstract available.

PMID:
11963512
28.

Inactivation of pulmonary surfactant and the treatment of acute lung injuries.

Taeusch HW, Keough KM.

Pediatr Pathol Mol Med. 2001 Nov-Dec;20(6):519-36. Review.

PMID:
11699577
29.

Thermal stability and DPPC/Ca2+ interactions of pulmonary surfactant SP-A from bulk-phase and monolayer IR spectroscopy.

Bi X, Taneva S, Keough KM, Mendelsohn R, Flach CR.

Biochemistry. 2001 Nov 13;40(45):13659-69.

PMID:
11695915
30.

The editor interviews ... Kevin Keough, Chief Scientist, Health Canada. Interview by Dr. Peggy Leatt.

Keough K.

Hosp Q. 2000-2001 Winter;4(2):64-5. No abstract available.

PMID:
11592250
31.

Intrinsic structural differences in the N-terminal segment of pulmonary surfactant protein SP-C from different species.

Plasencia I, Rivas L, Casals C, Keough KM, Pérez-Gil J.

Comp Biochem Physiol A Mol Integr Physiol. 2001 May;129(1):129-39.

PMID:
11369538
32.

Putting the "affirm" into affirmative action: preferential selection and academic performance.

Brown RP, Charnsangavej T, Keough KA, Newman ML, Rentfrow PJ.

J Pers Soc Psychol. 2000 Nov;79(5):736-47.

PMID:
11079238
33.

Pulmonary surfactant protein A interacts with gel-like regions in monolayers of pulmonary surfactant lipid extract.

Worthman LA, Nag K, Rich N, Ruano ML, Casals C, Pérez-Gil J, Keough KM.

Biophys J. 2000 Nov;79(5):2657-66.

35.

Microstructure and dynamic surface properties of surfactant protein SP-B/dipalmitoylphosphatidylcholine interfacial films spread from lipid-protein bilayers.

Cruz A, Worthman LA, Serrano AG, Casals C, Keough KM, Pérez-Gil J.

Eur Biophys J. 2000;29(3):204-13.

PMID:
10968212
37.

Elevated levels of urine angiostatin and plasminogen/plasmin in cancer patients.

Cao Y, Veitonmaki N, Keough K, Cheng H, Lee LS, Zurakowski D.

Int J Mol Med. 2000 May;5(5):547-51.

PMID:
10762660
38.

Interesterification (acidolysis) of butterfat with conjugated linoleic acid in a batch reactor.

Garcia HS, Keough KJ, Arcos JA, Hill CG Jr.

J Dairy Sci. 2000 Mar;83(3):371-7.

39.

Insulin-induced vascular endothelial growth factor expression in retina.

Lu M, Amano S, Miyamoto K, Garland R, Keough K, Qin W, Adamis AP.

Invest Ophthalmol Vis Sci. 1999 Dec;40(13):3281-6.

PMID:
10586954
40.

Interactions of pulmonary surfactant protein A with phospholipid monolayers change with pH.

Ruano ML, Nag K, Casals C, Pérez-Gil J, Keough KM.

Biophys J. 1999 Sep;77(3):1469-76.

41.

Elevated serum vascular endothelial growth factor in children and young adults with Crohn's disease.

Bousvaros A, Leichtner A, Zurakowski D, Kwon J, Law T, Keough K, Fishman S.

Dig Dis Sci. 1999 Feb;44(2):424-30.

PMID:
10063933
43.

Interfacial properties of surfactant proteins.

Pérez-Gil J, Keough KM.

Biochim Biophys Acta. 1998 Nov 19;1408(2-3):203-17. Review. No abstract available.

44.

Zinc-binding of endostatin is essential for its antiangiogenic activity.

Boehm T, O'reilly MS, Keough K, Shiloach J, Shapiro R, Folkman J.

Biochem Biophys Res Commun. 1998 Nov 9;252(1):190-4.

PMID:
9813168
45.

Phase transitions in films of lung surfactant at the air-water interface.

Nag K, Perez-Gil J, Ruano ML, Worthman LA, Stewart J, Casals C, Keough KM.

Biophys J. 1998 Jun;74(6):2983-95.

46.

Urinary basic fibroblast growth factor. A biochemical marker for preosseous fibroproliferative lesions in patients with fibrodysplasia ossificans progressiva.

Kaplan F, Sawyer J, Connors S, Keough K, Shore E, Gannon F, Glaser D, Rocke D, Zasloff M, Folkman J.

Clin Orthop Relat Res. 1998 Jan;(346):59-65.

PMID:
9577411
47.
48.
49.

Advanced glycation end products increase retinal vascular endothelial growth factor expression.

Lu M, Kuroki M, Amano S, Tolentino M, Keough K, Kim I, Bucala R, Adamis AP.

J Clin Invest. 1998 Mar 15;101(6):1219-24.

Supplemental Content

Loading ...
Support Center